Site IndexContact UsHome
Johns Hopkins Medicine Research

November 2002
EDITORIALS - Back

HIPAA Will Affect Research At Hopkins

You may have heard that "HIPAA" will affect research activities at Hopkins in the near future. What you have heard is correct! The privacy regulations under the Health Insurance Portability and Accountability Act, better known as HIPAA, are intended to protect the privacy of identifiable health information ("protected health information" or "PHI") which health care providers use or disclose in the course of their activities. Most Hopkins entities are "covered entities" under the regulations, including the School of Medicine, the School of Nursing and parts of the Bloomberg School of Public Health and Whiting School of Engineering. Research is one of the activities that is covered under these new regulations for the Hopkins entities.

The University and the Health System have set up a centralized HIPAA Office which will, in the next two to three months, help researchers, IRBs, administrators, and staff understand the rules and how they will apply to research activities. There will be meetings, brochures, and on-line teaching modules to assist in the education process. Because the regulations become effective April 14, 2003, time is of the essence.

As a preview, following are some of the things which HIPAA will require as Hopkins addresses these new rules:

  • In addition to the informed consent currently required under the Common Rule, researchers also will need to get, and IRBs will need to approve, a privacy authorization from research participants.
  • For ongoing research protocols that will be enrolling participants on or after April 14, 2003, researchers will need to use this new privacy authorization. (The HIPAA and IRB Offices are establishing a streamlined process to help this happen on time.)
  • If a researcher requests a waiver of consent or a waiver of written consent under the Common Rule, the IRB will need to make special privacy findings in addition to those findings necessary under the Common Rule.
  • If researchers wish to look at patients’ records in their preparation for research, researchers will need to make some simple, straightforward representations to the IRB as to the research purposes for their use of the patients’ records.
  • Even though research on decedents’ records generally does not require IRB review under the Common Rule, under the HIPAA regulations, researchers will need to make some simple, straightforward representations to the IRB as to the research purpose for their use or disclosure of decedents’ files in research.
  • Researchers must use and disclose only the protected health information (PHI) needed for their research purposes -- and no more. This is referred to as the "minimum necessary" rule.
  • If a researcher has created a separate research database and the principal purpose of the database is availability for future research, the creation of the database needs to be acknowledged and "grandfathered" through a waiver by the IRB. (Again, the IRB and HIPAA Offices are working on a streamlined form for this activity.)
  • Hopkins needs to keep a record of disclosures of PHI that are made in connection with waived research, research using decedents’ records, and reviews preparatory to research. (The IRB Offices and the HIPAA Office will need the help of researchers and are working on streamlined ways to do this.)

There will be a lot of information coming to you on HIPAA and on the privacy regulations in the near future. In the meantime, if you would like more information click here: http://www.insidehopkinsmedicine.org/hipaa/


JHMI Microarray Core News

The JHMI Microarray Core Facility Analysis Unit invites microarray researchers to create an account and use elements of our software menu and advising support, completely free of charge, for a trial period as we begin full implementation of our activities. The facility supplies access to commercial analysis software (including GeneSpring, GeneSight, ImaGene, Spotfire, MicroArray Suite, Affymetrix DataMiningTool), and expert support for using these in addition to academic packages (including dChip, Cluster/Treeview, and BioConductor). Microarray data storage and sharing are enhanced by a GenoMax Expression Module database, which offers user-defined sharing properties and includes server-supported analytical tools. GenoMax access and nearly all software are provided through browser interfaces for both PC and Macintosh desktop environments. The JHMI Microarray Core Hybridization Unit continues to offer Affymetrix GeneChip hybridization services. For current chip pricing, analysis account signup, and other Core news, please visit our website at: www.microarray.jhmi.edu.

Return to top of Editorials

 
   
November 2002 articles:
JHM IRB Launches New Web site

Rodent Breeding and Colony Management Symposium
Animal Care and Use Committee Seminars

Material Transfer Agreement Process Made Simple

Web site Developed as Guide for Private Written Agreements

Albany Medical Center Prize
Sandler Program for Asthma Research

Revised PHS 416-1, PHS 416-9, and Related Forms Now Available
NIH Extramural Loan Repayment Program Regarding Clinical Researchers (LRP-CR)
NIH Loan Repayment Program for Pediatric Researchers (PR-LRP)

HIPAA Will Affect Research At Hopkins
JHMI Microarray Core News



 

Johns Hopkins Medicine
© Copyright 2003 | All Rights Reserved | Johns Hopkins University
School of Medicine
720 Rutland Avenue, Baltimore, Maryland 21205 USA